SEC Tracker
Get the app

KalVista Pharmaceuticals KALV

Edward W Unkart, insider filing for KALV

Form
4
Filed
Importance
Routine

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when KalVista Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Kura Oncology KURA public float $496M, Jun 30, 2025
  2. Myriad Genetics MYGN public float $494M, Jun 30, 2025
  3. Arbutus Biopharma ABUS public float $472M, Jun 30, 2025
  4. Arvinas ARVN public float $469M, Jun 30, 2025
  5. Elite Pharmaceuticals ELTP public float $534M, Sep 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.